Volume 11, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



In clinical trials of dehydroemetine, a new synthetic compound, the results in acute amebic dysentery were similar to those obtained with emetine hydrochloride, and 17 of 19 patients with amebic liver abscess apparently were cured. Significant toxicity was not encountered.

Before claims to replace the established position of emetine hydrochloride in the treatment of amebiasis can be advanced, more extensive, long-term experience of dehydroemetine is necessary. Nevertheless the advent of this drug represents a significant step towards the development of a less toxic and more efficient emetine-like compound.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...


Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error